Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2025-12-31 @ 5:46 PM
Study NCT ID:
NCT03527108
Status:
RECRUITING
Last Update Posted:
2025-07-04
First Post:
2018-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC
Sponsor:
Fox Chase Cancer Center